AllanD.KirkMDPhD
General Surgery • Durham, NCHepatobiliary Surgery, Pancreas, Transplantation
David C. Sabiston, Jr. Professor and Chairman of Surgery, Duke University School of Medicine; Surgeon-in-Chief, Duke University Health System
Dr. Kirk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2301 Duke Medical Ctr
7th Floor, Room 7690 HAFS Building
Durham, NC 27710Phone+1 919-681-3445- Is this information wrong?
Summary
- Dr. Allan Kirk is Chair of the Department of Surgery at Duke University and Surgeon-in-Chief for the Duke Health System. He received his medical degree and PhD from Duke University School of Medicine and has been in practice 30 years. He specializes in transplantation and is experienced in kidney and pancreas transplantation, transplant surgery, hepatopancreatobiliary surgery, pediatric transplant surgery, and immune tolerance.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Abdominal Transplant Surgery, 1995 - 1997
Duke University HospitalResidency, Surgery, 1987 - 1995
Duke UniversityPhD, 1989 - 1992
Duke University School of MedicineClass of 1987
Certifications & Licensure
GA State Medical License 2007 - 2024
NC State Medical License 1990 - 2024
VA State Medical License 1998 - 2022
WI State Medical License 1995 - 2007- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Elected Member National Academy of Medicine
- Elected member American Surgical Association
- Elected Member The American Society for Clinical Investigation, 2007
- Join now to see all
Clinical Trials
- Belatacept Post Depletional Repopulation to Facilitate Tolerance Start of enrollment: 2007 Dec 01
- Immune Development in Pediatric Transplantation (IMPACT) Start of enrollment: 2009 Jul 01
- Immune Monitoring and Assay Development in Organ Transplant Recipients Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsDefining the Need for Causal Inference to Understand the Impact of Social Determinants of Health: A Primer on Behalf of the Consortium for the Holistic Assessment of R...Bhavsar, N., Patzer, R., Taber, D., Ross-Driscoll, K., Deierhoi Reed, R., Caicedo-Ramirez, J., Gordon, E., Matsouaka, R., Rogers, U., Webster, W., Adams, A., Kirk, A.,...> ;Annals of Surgery Open. 2023 Dec 1
- 4 citationsThe anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.Imran J Anwar, Dora M Berman, Qimeng Gao, Melissa A Willman, Allison Miller, Alan Gill, Cindy Gill, Steve Perrin, Camillo Ricordi, Philip Ruiz, Mingqing Song, Joseph M...> ;Science Translational Medicine. 2023 Aug 30
- 2 citationsOpen letter to Bristol Myers Squibb: Belatacept; we aren't done yet.Flavio Vincenti, Klemens Budde, Josep Grinyo, Lionel Rostaing, Allan D Kirk, Christian P Larsen> ;American Journal of Transplantation. 2023 Oct 1
- Join now to see all
Press Mentions
Clinetic Establishes Partnership with 10th Leading Academic Health SystemFebruary 15th, 2023- Clinetic Establishes Agreement with 10th Leading Academic Health SystemFebruary 15th, 2023
- FDA Planning to Allow Clinical Trials of Pig Organ TransplantsJune 30th, 2022
- Join now to see all
Grant Support
- Adjuvant Therapies Improving The Anti-Rejection Effects Of Costimulation BlockadeNational Institute Of Allergy And Infectious Diseases2009–2012
- Development Of Transplant Strategies Uniquely Responsive To The Needs Of ChildrenNational Institute Of Allergy And Infectious Diseases2008–2012
- Neonatal Porcine Islet Xenografts For The Treatment Of Type 1 DiabetesNational Institute Of Allergy And Infectious Diseases2010–2011
- Adjuvant Therapies Improving Anti-Rejection Effects Of Costimulation BlockadeNational Center For Research Resources2010–2011
- A Phase 2 Tolerance Trial Of Belatacept And Alemtuzumab In Renal TransplantationFood And Drug Administration2008–2011
- NPH Renal &Skin Transplantation For Allospecific Tolerance InductionNational Center For Research Resources2009
- Development Of Methods For Inducing Solid Organ Transplant ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Kidney/Pancreas Allograft Rejection: Clinical Studies AnNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Development Of Methods For Inducing Solid Organ TransplaNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Kidney/Pancreas Allograft Rejection--Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Methods For Inducing Solid Organ Transplant ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Kidney/Pancreas Allograft RejectionNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Kidney/Pancreas Allograft Rejection: Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Efficacy Of Costimulation Blockade In Preventing, Treating Allograft RejectionNational Institute Of Allergy And Infectious Diseases1998–2001
- Human Renal Allograft-Derived Mucin-Specific T CellsNational Institute Of Allergy And Infectious Diseases1991–1992
Professional Memberships
- Member
Hospital Affiliations
Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
